Interleukin-33 keeping liver facilitated recurrence of cholangiocarcinoma through indirect influence

被引：0
|
作者：
Nagaoka, Satoshi [1 ]
Yamada, Daisaku [1 ]
Eguchi, Hidetoshi [1 ]
Iwagami, Yoshifumi [1 ]
Asaoka, Tadafumi [1 ]
Noda, Takehiro [1 ]
Kawamoto, Koichi [1 ]
Gotoh, Kunihito [1 ]
Kobayashi, Syogo [1 ]
Umeshita, Koji [2 ]
Doki, Yuichiro [1 ]
Mori, Masaki [1 ]
机构：
[1] Osaka Univ, Dept Gastroenterol Surg, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Div Hlth Sci, Osaka, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
O-0519
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [41] Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway
    Yao, Yongwei
    Chen, Rong
    Ying, Chunyang
    Zhang, Guohui
    Rui, Tao
    Tao, Aibin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (03) : 1288 - 1295
  • [42] INTERLEUKIN-33 REGULATES THE DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE THROUGH ITS RECEPTOR ST2 IN ENTERIC GLIAL CELLS
    Nie, Kai
    Yang, Yuanyuan
    Wang Xiaoyan
    GASTROENTEROLOGY, 2022, 162 (07) : S979 - S980
  • [43] In acromegalic patients the serum levels of interleukin-33 and Resolvin D1 influence skin perfusion of hands: A pilot study
    Costa, Denise
    Pellicano, Chiara
    Mercuri, Valeria
    Arnone, Jacopo Maria
    Rizzo, Flavio
    Leodori, Giorgia
    Gargiulo, Patrizia
    Rosato, Edoardo
    MICROVASCULAR RESEARCH, 2023, 149
  • [44] Interleukin-33 and Its Receptor, ST2, Are Dysregulated in Gastritis and Gastric Cancer and May Influence Gastric Epithelial Proliferation
    Pisani, Laura F.
    Tontini, Gian Eugenio
    Bona, Davide
    Bonavina, Luigi
    Vecchi, Maurizio
    Pastorelli, Luca
    GASTROENTEROLOGY, 2015, 148 (04) : S564 - S564
  • [45] MESENCHYMAL STEM CELLS PRETREATED WITH INTERLEUKIN-33 ATTENUATE ACUTE LIVER FAILURE BY IMPROVING MIGRATION AND POLARIZING M2 MACROPHAGES
    Yuan, Hui
    Song, Jiali
    Peng, Linya
    Zhu, Chuanlong
    HEPATOLOGY, 2023, 78 : S1970 - S1971
  • [46] Down-regulated SHARPIN may accelerate the development of atopic dermatitis through activating interleukin-33/ST2 signalling
    Tang, Lingjie
    Wang, Jiaman
    Zhu, Jingna
    Liang, Yanhua
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (12) : 1328 - 1335
  • [47] Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
    Tong, Xiaoguang
    Barbour, Mark
    Hou, Kezuo
    Gao, Chao
    Cao, Shuang
    Zheng, Jingli
    Zhao, Yang
    Mu, Rong
    Jiang, Hui-Rong
    MOLECULAR ONCOLOGY, 2016, 10 (01) : 113 - 125
  • [48] Interleukin-33, a Potential Cytokine Expressed in Tumor Microenvironment Involves in Antitumor Immunotherapy Through Facilitates CD8+ T Cells
    Li, Xiaochen
    Lv, Quansheng
    Feng, Yuehua
    Gu, Yanzheng
    Xia, Rui
    Ma, Jingshu
    He, Honghong
    Zhu, Yibei
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2018, 38 (11): : 491 - 499
  • [49] Early activation and recruitment of invariant natural killer T cells during liver ischemia-reperfusion: the major role of the alarmin interleukin-33
    Robin, Aurelie
    Mackowiak, Claire
    Bost, Romain
    Dujardin, Fanny
    Barbarin, Alice
    Thierry, Antoine
    Hauet, Thierry
    Pellerin, Luc
    Gombert, Jean-Marc
    Salame, Ephrem
    Herbelin, Andre
    Barbier, Louise
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway
    Wang, Shenyu
    Zhao, Gongyin
    Zhao, Shujie
    Qiao, Yusen
    Yang, Huilin
    MEDICAL SCIENCE MONITOR, 2020, 26
12345